Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 11 results.
User Information
Export Records
  1. 1.   Effects of substituent pattern on the intracellular target of antiproliferative benzo[b]thiophenyl chromone derivatives
  2. Saito, Yohei; Taniguchi, Yukako; Hirazawa, Sachika; Miura, Yuta; Tsurimoto, Hiroyuki; Nakayoshi, Tomoki; Oda, Akifumi; Hamel,Ernest; Yamashita, Katsumi; Goto, Masuo; Nakagawa-Goto, Kyoko
  3. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. 2021, OCT 15; 222
  1. 2.   Proteomic Analysis of Nuclei Isolated from Cancer Cell Lines Treated with Indenoisoquinoline NSC 724998, a Novel Topoisomerase I Inhibitor
  2. Han, B. N.; Stockwin, L. H.; Hancock, C.; Yu, S. X.; Hollingshead, M. G.; Newton, D. L.
  3. Journal of Proteome Research. 2010, Aug 6; 9(8): 4016-4027.
  1. 3.   Arylstibonic acids: Novel inhibitors and activators of human topoisomerase IB
  2. Kim, H.; Cardellina, J. H.; Akee, R.; Champoux, J. J.; Stivers, J. T.
  3. Bioorganic Chemistry. 2008 36(4-6): 190-197.
  1. 4.   Immunization with DNA topoisomerase I induces autoimmune responses but not scleroderma-like pathologies in mice
  2. Hu, P. Q.; Hurwitz, A. A.; Oppenheim, M. J.
  3. Journal of Rheumatology. 2007, Nov; 34(11): 2243-2252.
  1. 5.   Tumor suppressor Pdcd4 inhibits invasion/intravasation and regulates urokinase receptor (u-PAR) gene expression via Sp-transcription factors
  2. Leupold, J. H.; Yang, H. S.; Colburn, N. H.; Asangani, I.; Post, S.; Allgayer, H.
  3. Oncogene. 2007, Jul; 26(31): 4550-4562.
  1. 6.   Synthesis and biological activity of 5-aza-ellipticine derivatives
  2. Moody, D. L.; Dyba, M.; Kosakowska-Cholody, T.; Tarasova, N. I.; Michejda, C. I.
  3. Bioorganic & Medicinal Chemistry Letters. 2007, Apr; 17(8): 2380-2384.
  1. 7.   Evaluation of indenoisoquinoline topoisomerase I inhibitors using a hollow fiber assay
  2. Morrell, A.; Jayaraman, M.; Nagarajan, M.; Fox, B. M.; Meckley, M. R.; Ioanoviciu, A.; Pommier, Y.; Antony, S.; Hollineshead, M.; Cushman, M.
  3. Bioorganic & Medicinal Chemistry Letters. 2006, Aug; 16(16): 4395-4399.
  1. 8.   Antitumor activity and distribution of pyrroloiminoquinones in the sponge genus Zyzzya
  2. Dijoux, M. G.; Schnabel, P. C.; Hallock, Y. F.; Boswell, J. L.; Johnson, T. R.; Wilson, J. A.; Irel, C. M.; van Soest, R.; Boyd, M. R.; Barrows, L. R.; Cardellina, J. H.
  3. Bioorganic & Medicinal Chemistry. 2005, NOV 1; 13(21): 6035-6044.
  1. 9.   Introduction and overview. Perinatal carcinogenesis: growing a node for epidemiology, risk management, and animal studies
  2. Anderson, L. M.
  3. Toxicology and Applied Pharmacology. 2004, SEP 1; 199(2): 85-90.
  1. 10.   Characterization of programmed cell death 4 in multiple human cancers reveals a novel enhancer of drug sensitivity
  2. Jansen, A. P.; Camalier, C. E.; Stark, C.; Colburn, N. H.
  3. Molecular Cancer Therapeutics. 2004 3(2): 103-110.
  1. 11.   Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation
  2. Cmarik, J. L.; Min, H. Z.; Hegamyer, G.; Zhan, S. N.; Kulesz-Martin, M.; Yoshinaga, H.; Matsuhashi, S.; Colburn, N. H.
  3. Proceedings of the National Academy of Sciences of the United States of America. 1999 96(24): 14037-14042.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel